For Patients With HIV-Associated Fungal Infections, Single High-Dose LAmB Has Lowest Risk For Life-Threatening Adverse Events Compared To Other Amphotericin B Treatments, Study Finds

Infectious Disease Advisor (10/19, Nye) reports, “For patients with HIV-associated fungal infections, single high-dose liposomal amphotericin B (LAmB) has the lowest risk for life-threatening adverse events (AEs) when compared with other amphotericin B-ba...